Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells

Muhammad Mushtaq; Pradeepa N. Pangigadde; Suhas Darekar; Erik Dissen; Elena Kashuba

doi:10.18632/oncotarget.17610

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells

Muhammad Mushtaq, Pradeepa N. Pangigadde, Suhas Darekar, Erik Dissen and Elena Kashuba _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:64907-64917. https://doi.org/10.18632/oncotarget.17610

Metrics: PDF 2051 views | HTML 2416 views | ?

Abstract

Muhammad Mushtaq1, Pradeepa N. Pangigadde1,2, Suhas Darekar1, Erik Dissen3 and Elena Kashuba1,4

1 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2 University “Magna Græcia” of Catanzaro, Viale Europa, Catanzaro, Italy

3 Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

4 R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NASU, Ukraine

Correspondence to:

Elena Kashuba, email:

Keywords: mitochondrial ribosomal protein MRPS18-2, cell immortalization, stem cells, NK killing, cytokine expression profile

Received: March 16, 2017 Accepted: April 24, 2017 Published: May 04, 2017

Abstract

Overexpression of the human mitochondrial ribosomal protein MRPS18-2 (S18-2) led to immortalization of primary rat embryonic fibroblasts (REFs). The derived cells (18IM) expressed embryonic stem cell markers. Noteworthy, genes encoding the COX family proteins were up-regulated significantly. It is known that the COX family proteins are involved in the regulation of immune response.

In the present work we demonstrate that 18IM cells behave like stem cells when subjected to directed differentiation in vitro. However, unlike stem cells, 18IM cells do not develop tumors in vivo, in SCID mice. This phenomenon is observed due to the strong natural killer (NK) cell immunogenicity. 18IM cells were better recognized by NK cells, compared with primary REFs, as was shown by a standard NK killing assay.

Our data explain asymmetry in behavior of stem-like cells in vivo and in vitro, and this support the notion that stem and/or cancer-initiating cells are preferred targets for NK-cells. Concluding, the S18-2 protein is a putative target for cancer vaccines.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17610

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Rat embryonic fibroblasts immortalized by MRPS18-2 protein are target for NK-cells

Abstract